文献
J-GLOBAL ID:202202283978329206
整理番号:22A0428316
ロバスタチンはCYP2C8の阻害を介してパクリタキセル耐性前立腺癌細胞の化学感受性を増強する【JST・京大機械翻訳】
Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8
著者 (19件):
Li Ying
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Li Ying
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Chen Sisi
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Chen Sisi
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Zhu Jianyu
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Zhu Jianyu
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Zhu Jianyu
(Department of Pathophysiology, Jishou University School of Medicine, Jishou, 416000, China)
,
Zheng Chanjuan
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Zheng Chanjuan
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Wu Muyao
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Wu Muyao
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Xue Lian
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Xue Lian
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
He Guangchun
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
He Guangchun
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Fu Shujun
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Fu Shujun
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Deng Xiyun
(Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
,
Deng Xiyun
(Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, 410013, China)
資料名:
Biochemical and Biophysical Research Communications
(Biochemical and Biophysical Research Communications)
巻:
589
ページ:
85-91
発行年:
2022年
JST資料番号:
B0118A
ISSN:
0006-291X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)